Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $1.2 Million - $1.54 Million
-20,355 Reduced 56.86%
15,445 $1.14 Million
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $12,001 - $18,025
-182 Reduced 0.51%
35,800 $2.44 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $345,053 - $523,250
5,505 Added 18.06%
35,982 $3.38 Million
Q1 2023

Dec 19, 2024

BUY
$47.19 - $70.77 $1.44 Million - $2.16 Million
30,477 New
30,477 $2.07 Million
Q1 2023

May 12, 2023

SELL
$47.19 - $70.77 $388,468 - $582,578
-8,232 Reduced 21.27%
30,477 $2.07 Million
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $744,880 - $1.3 Million
24,543 Added 173.25%
38,709 $1.92 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $452,887 - $699,375
14,166 New
14,166 $460,000
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $441,044 - $655,822
-4,709 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $548,928 - $729,942
4,709 New
4,709 $621,000
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $296,240 - $422,664
-2,974 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $216,864 - $303,377
2,974 New
2,974 $303,000
Q2 2020

Aug 10, 2020

SELL
$55.75 - $92.75 $142,887 - $237,718
-2,563 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$37.9 - $104.44 $97,137 - $267,679
2,563 New
2,563 $149,000
Q2 2019

Aug 12, 2019

SELL
$89.51 - $118.04 $71,608 - $94,432
-800 Closed
0 $0
Q1 2019

May 02, 2019

BUY
$61.98 - $96.5 $49,584 - $77,200
800 New
800 $70,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.